ZA200108130B - Treatment of pulmonary hypertension. - Google Patents

Treatment of pulmonary hypertension.

Info

Publication number
ZA200108130B
ZA200108130B ZA200108130A ZA200108130A ZA200108130B ZA 200108130 B ZA200108130 B ZA 200108130B ZA 200108130 A ZA200108130 A ZA 200108130A ZA 200108130 A ZA200108130 A ZA 200108130A ZA 200108130 B ZA200108130 B ZA 200108130B
Authority
ZA
South Africa
Prior art keywords
pulmonary hypertension
treatment
preparation
pharmaceutical composition
treating pulmonary
Prior art date
Application number
ZA200108130A
Other languages
English (en)
Inventor
Maha Ghazzi
Milton Lethan Pressler
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA200108130B publication Critical patent/ZA200108130B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200108130A 2000-10-04 2001-10-03 Treatment of pulmonary hypertension. ZA200108130B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23753800P 2000-10-04 2000-10-04

Publications (1)

Publication Number Publication Date
ZA200108130B true ZA200108130B (en) 2002-06-06

Family

ID=22894157

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200108130A ZA200108130B (en) 2000-10-04 2001-10-03 Treatment of pulmonary hypertension.

Country Status (13)

Country Link
US (1) US6740648B2 (de)
EP (1) EP1195166B1 (de)
JP (1) JP3838065B2 (de)
KR (1) KR100445946B1 (de)
AT (1) ATE367815T1 (de)
CA (1) CA2357833C (de)
DE (1) DE60129518T2 (de)
ES (1) ES2288899T3 (de)
HU (1) HUP0104085A3 (de)
IL (1) IL145684A (de)
MY (1) MY136383A (de)
NZ (1) NZ514542A (de)
ZA (1) ZA200108130B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI322689B (en) * 2003-02-24 2010-04-01 Otsuka Pharma Co Ltd Method for treating severe heart failure and medicament therefor
US20050159985A1 (en) * 2003-11-21 2005-07-21 Bertram Carl T. System and method of stratifying intervention groups and comparison groups based on disease severity index scores and ranges
US10042980B2 (en) 2005-11-17 2018-08-07 Gearbox Llc Providing assistance related to health
US8532938B2 (en) 2005-11-17 2013-09-10 The Invention Science Fund I, Llc Testing-dependent administration of a nutraceutical
US20070112592A1 (en) 2005-11-17 2007-05-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Payments in providing assistance related to health
US8468029B2 (en) 2005-11-17 2013-06-18 The Invention Science Fund I, Llc Subscriptions for assistance related to health
US10296720B2 (en) 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US8340944B2 (en) 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20080210748A1 (en) 2005-11-30 2008-09-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware, Systems and methods for receiving pathogen related information and responding
US8000981B2 (en) * 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US8297028B2 (en) 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
US7974856B2 (en) 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
WO2007087575A2 (en) * 2006-01-24 2007-08-02 University Of Chicago Compositions and methods for treating pulmonary hypertension
CN103450077B (zh) 2007-06-08 2016-07-06 满康德股份有限公司 IRE-1α抑制剂
AU2009257174A1 (en) * 2008-06-09 2009-12-17 Dimerix Bioscience Pty Ltd Novel receptor hetero-dimers/-oligomers
CN103260670A (zh) 2010-10-15 2013-08-21 塞托弗尔克斯股份有限公司 细胞分离灌流器及其用途
EP2766065A4 (de) 2011-10-14 2016-06-15 Cytopherx Inc Patrone und verfahren zur erhöhung der herzmuskelfunktion
WO2014062888A1 (en) * 2012-10-18 2014-04-24 University Of South Florida Compositions and methods for treating stroke
WO2015171989A1 (en) * 2014-05-08 2015-11-12 University Of Maryland, Baltimore Methods for assessing differential risk for developing heart failure
US10518112B2 (en) * 2014-06-18 2019-12-31 Sonivie Ltd. Method for treating secondary pulmonary hypertension
CN110237077A (zh) * 2019-05-10 2019-09-17 辽宁大学 考尼伐坦在制备降血脂药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225402A (en) 1989-02-10 1993-07-06 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
US5338755A (en) 1990-07-31 1994-08-16 Elf Sanofi N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present
GB9307527D0 (en) * 1993-04-13 1993-06-02 Fujisawa Pharmaceutical Co New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
DE69434032T2 (de) * 1993-07-21 2005-09-22 Yamanouchi Pharmaceutical Co., Ltd. Zwischenprodukt zur Herstellung von kondensierten Benzazepinderivate
NZ271454A (en) 1993-08-26 1997-07-27 Yamanouchi Pharma Co Ltd Difluoro substituted benzazepine derivatives and pharmaceutical compositions
CA2153498A1 (en) 1993-11-10 1995-05-18 Hidetsura Cho Chroman derivative and medicinal use thereof
FR2757157B1 (fr) * 1996-12-13 1999-12-31 Sanofi Sa Derives d'indolin-2-one, procede pour leur preparation et compositions pharmaceutiques les contenant
US6268359B1 (en) * 1998-01-28 2001-07-31 Senju Pharmaceutical Co., Ltd. Preventives or remedies for vision disorders
TR200102069T2 (tr) * 1999-01-19 2001-11-21 Ortho-Mcneil Pharmaceutical, Inc. Vasopresin reseptörü antagonistleri olarak trisiklik benzodiazepinler.
DE19906310A1 (de) * 1999-02-16 2000-08-17 Solvay Pharm Gmbh Arzneimittel zur Behandlung von Bluthochdruck

Also Published As

Publication number Publication date
CA2357833A1 (en) 2002-04-04
JP2002128696A (ja) 2002-05-09
DE60129518D1 (de) 2007-09-06
IL145684A (en) 2007-06-17
MY136383A (en) 2008-09-30
HUP0104085A2 (hu) 2002-07-29
ES2288899T3 (es) 2008-02-01
ATE367815T1 (de) 2007-08-15
JP3838065B2 (ja) 2006-10-25
EP1195166B1 (de) 2007-07-25
HU0104085D0 (en) 2001-12-28
KR100445946B1 (ko) 2004-08-25
CA2357833C (en) 2005-11-15
US20020128259A1 (en) 2002-09-12
NZ514542A (en) 2002-10-25
IL145684A0 (en) 2002-06-30
EP1195166A3 (de) 2003-12-03
EP1195166A2 (de) 2002-04-10
HUP0104085A3 (en) 2004-11-29
US6740648B2 (en) 2004-05-25
KR20020027237A (ko) 2002-04-13
DE60129518T2 (de) 2008-03-20

Similar Documents

Publication Publication Date Title
ZA200108130B (en) Treatment of pulmonary hypertension.
DE60018100D1 (en) Polymorphe form von atorvastatin-calcium
ZA200405657B (en) Formulation & dosage form for the controlled delivery of therapeutic agents.
AP1718A (en) 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors
EP1399414A4 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
GB0111523D0 (en) Chemical compounds
SI1292594T1 (en) Quinazoline derivatives for the treatment of tumours
SI2092935T1 (sl) Farmacevtski sestavek za zdravljenje astme
PL350412A1 (en) 2−amino−benzoxazinone derivatives for the treatment of obesity
ZA200109073B (en) Compositions for treatment of disorders of the oesophagus.
HUP0004211A3 (en) Use of pde-5 inhibitors for the preparation of pharmaceutical compositions treating pulmonary hypertension
IL192991A0 (en) Use of tetrahydrocarbazole derivatives for the manufacture of medicanents for treating gonadotropin-releasing hormone
HK1057363A1 (en) Ccr5 antagonists useful for treating aids.
PL350167A1 (en) Medicament for treating hypertension
MXPA03002909A (es) Compuestos quimicos.
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
AU7287201A (en) Novel form of (R)-N-(5-methyl-8-(4-methylpiperazin-1-YL)-1,2,3,4-tetrahydro-2-naphthyl)-4-morpholinobenzamide
ZA200500431B (en) Medicinal composition for treating arteriosclerosis
DE60134735D1 (de) Neue neurokinin-antagonisten zum gebrauch als arzneimittel
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
IL155706A0 (en) Process for the preparation of (r)-5-(2-benzenesulfonylethyl)-3-(n-methylpyrrolidin-2-ylmethyl)-1h-indole
MXPA03001472A (es) Compuestos para el tratamiento de trastornos adictivos.
NZ516209A (en) Indoloazepines as vasopressin receptor antagonists
ZA200000313B (en) Neuropeptide Y antagonists.
ZA200205835B (en) Compounds useful for the treatment or prevention of a disease mediated by the alpha-2B-adrenoceptor.